NEW YORK (360Dx) – Point-of-care diagnostic firm Chembio Diagnostics said Tuesday it has completed its buy of RVR Diagnostics, a privately held Malaysian POC Dx firm.

The deal was originally announced in November. Chembio CEO John Sperzel said in a statement that the acquisition is a key component of the firm's plans to grow its footprint in Europe, the Middle East, Africa and the Asia-Pacific region. The New York-based company also recently hired Robert Passas to oversee that strategy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.